Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2140764444;64445;64446 chr2:178586682;178586681;178586680chr2:179451409;179451408;179451407
N2AB1976659521;59522;59523 chr2:178586682;178586681;178586680chr2:179451409;179451408;179451407
N2A1883956740;56741;56742 chr2:178586682;178586681;178586680chr2:179451409;179451408;179451407
N2B1234237249;37250;37251 chr2:178586682;178586681;178586680chr2:179451409;179451408;179451407
Novex-11246737624;37625;37626 chr2:178586682;178586681;178586680chr2:179451409;179451408;179451407
Novex-21253437825;37826;37827 chr2:178586682;178586681;178586680chr2:179451409;179451408;179451407
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Fn3-43
  • Domain position: 42
  • Structural Position: 44
  • Q(SASA): 0.2712
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/G rs1413732448 None 0.379 N 0.475 0.17 0.319402600006 gnomAD-3.1.2 6.58E-06 None None None None N None 0 0 0 0 0 None 0 0 1.47E-05 0 0
E/G rs1413732448 None 0.379 N 0.475 0.17 0.319402600006 gnomAD-4.0.0 6.09034E-06 None None None None N None 0 0 None 0 0 None 0 0 7.22986E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.2957 likely_benign 0.2282 benign -0.553 Destabilizing 0.004 N 0.225 neutral N 0.503109491 None None N
E/C 0.9386 likely_pathogenic 0.9022 pathogenic -0.458 Destabilizing 0.992 D 0.581 neutral None None None None N
E/D 0.3369 likely_benign 0.2902 benign -1.362 Destabilizing 0.004 N 0.202 neutral N 0.478424478 None None N
E/F 0.9346 likely_pathogenic 0.8941 pathogenic 0.311 Stabilizing 0.972 D 0.56 neutral None None None None N
E/G 0.4291 ambiguous 0.3327 benign -0.993 Destabilizing 0.379 N 0.475 neutral N 0.500570619 None None N
E/H 0.847 likely_pathogenic 0.768 pathogenic -0.027 Destabilizing 0.92 D 0.431 neutral None None None None N
E/I 0.6356 likely_pathogenic 0.5286 ambiguous 0.667 Stabilizing 0.85 D 0.567 neutral None None None None N
E/K 0.469 ambiguous 0.3467 ambiguous -0.765 Destabilizing 0.016 N 0.211 neutral N 0.486811887 None None N
E/L 0.5553 ambiguous 0.4558 ambiguous 0.667 Stabilizing 0.617 D 0.513 neutral None None None None N
E/M 0.6523 likely_pathogenic 0.5478 ambiguous 1.074 Stabilizing 0.992 D 0.512 neutral None None None None N
E/N 0.6535 likely_pathogenic 0.5457 ambiguous -1.383 Destabilizing 0.447 N 0.399 neutral None None None None N
E/P 0.6296 likely_pathogenic 0.532 ambiguous 0.283 Stabilizing 0.92 D 0.417 neutral None None None None N
E/Q 0.3053 likely_benign 0.2387 benign -1.147 Destabilizing 0.099 N 0.223 neutral N 0.489505476 None None N
E/R 0.6225 likely_pathogenic 0.5117 ambiguous -0.45 Destabilizing 0.447 N 0.387 neutral None None None None N
E/S 0.4915 ambiguous 0.3825 ambiguous -1.737 Destabilizing 0.447 N 0.393 neutral None None None None N
E/T 0.4766 ambiguous 0.3624 ambiguous -1.359 Destabilizing 0.617 D 0.396 neutral None None None None N
E/V 0.4177 ambiguous 0.3196 benign 0.283 Stabilizing 0.379 N 0.481 neutral N 0.472435649 None None N
E/W 0.976 likely_pathogenic 0.96 pathogenic 0.518 Stabilizing 0.992 D 0.648 neutral None None None None N
E/Y 0.9104 likely_pathogenic 0.8533 pathogenic 0.557 Stabilizing 0.972 D 0.537 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.